Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus-Type 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05136703
What this trial is testing

Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)

Who this might be right for
DepressionHIV-1-infectionInflammation
Florida International University 150
Early research (Phase 1)Study completedNCT00000777
What this trial is testing

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)

Who this might be right for
HIV InfectionsPregnancyHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Ended earlyNCT00195312
What this trial is testing

Study Evaluating Vaccine in Adults With HIV

Who this might be right for
HIV Infections
Wyeth is now a wholly owned subsidiary of Pfizer 91
Early research (Phase 1)Active Not RecruitingNCT07055451
What this trial is testing

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV

Who this might be right for
HIV-1-infection
Gilead Sciences 16
Testing effectiveness (Phase 2)Study completedNCT00530777
What this trial is testing

HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding

Who this might be right for
HIV InfectionsHerpes Simplex
University of Washington 148
Early research (Phase 1)Study completedNCT00000901
What this trial is testing

Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Post-approval studies (Phase 4)Study completedNCT01458977
What this trial is testing

Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors

Who this might be right for
HIVDyslipidemia
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 48
Early research (Phase 1)Study completedNCT00002218
What this trial is testing

A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients

Who this might be right for
HIV Infections
Parke-Davis 40
Testing effectiveness (Phase 2)Study completedNCT00002324
What this trial is testing

The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease

Who this might be right for
HIV Infections
Boehringer Ingelheim 250
Large-scale testing (Phase 3)Study completedNCT02345226
What this trial is testing

Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 881
Early research (Phase 1)Study completedNCT01950325
What this trial is testing

VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...

Who this might be right for
HIV-1 InfectionNeutralizing AntibodyMonoclonal Antibody+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 27
Not applicableWithdrawnNCT05724524
What this trial is testing

Exploratory Study on the Role of the Digestive Microbiota in Adults Living With HIV-1

Who this might be right for
HIV
Centre Hospitalier Universitaire de Nīmes
Testing effectiveness (Phase 2)Study completedNCT01543958
What this trial is testing

Sevelamer for Reducing Endotoxemia and Immune Activation

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 40
Testing effectiveness (Phase 2)Study completedNCT00299338
What this trial is testing

A Dose Response and Safety Study of Procaine HCl in HIV-Infected Patients

Who this might be right for
HIV Infections
Samaritan Pharmaceuticals, Inc 24
Testing effectiveness (Phase 2)Study completedNCT00376935
What this trial is testing

Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 99
Large-scale testing (Phase 3)Study completedNCT00098748
What this trial is testing

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects

Who this might be right for
HIV Infections
ViiV Healthcare 190
Not applicableUnknownNCT03164135
What this trial is testing

Safety of Transplantation of CRISPR CCR5 Modified CD34+ Cells in HIV-infected Subjects With Hematological Malignances

Who this might be right for
HIV-1-infection
Affiliated Hospital to Academy of Military Medical Sciences 5
Large-scale testing (Phase 3)Study completedNCT00440947
What this trial is testing

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 515
Early research (Phase 1)Study completedNCT05165550
What this trial is testing

Study of Single Ascending Doses of Elsulfavirine to Evaluate the Safety, Tolerability, and Pharmacokinetics of Elsulfavirine and Its Active Metabolite VM-1500A in Healthy Subjects

Who this might be right for
HIV-1-infection
Viriom 24
Not applicableStudy completedNCT04661813
What this trial is testing

Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV

Who this might be right for
HIV-1-infectionHypertension
Case Western Reserve University 81
Next Page